They applied prior biological knowledge of the involvement of CFH (also called HF1) in membranoproliferative glomerulonephritis type II (MPGNII), a disease in which patients develop ocular drusen nearly identical to those found in AMD patients. This evidence concerns the gene CFH and dense deposit disease.